0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.87.25. Please contact the publisher to request reinstatement.
Comment & Response |

Contaminated Methylprednisolone Injections—Reply

Anurag N. Malani, MD1; Bonita Singal, MD, PhD2; Carol A. Kauffman, MD3
[+] Author Affiliations
1Department of Internal Medicine, St Joseph Mercy Hospital, Ypsilanti, Michigan
2Department of Clinical Research, St Joseph Mercy Hospital, Ypsilanti, Michigan
3Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan
JAMA. 2013;310(16):1735-1736. doi:10.1001/jama.2013.277458.
Text Size: A A A
Published online

Extract

In Reply Dr Matuchansky raises concern about whether there was sufficient lag time between receipt of the last contaminated methylprednisolone injection and screening MRI for patients with MRI studies classified as normal or equivocal. The median time from last spinal or paraspinal injection to an abnormal MRI result was 87 days (range, 44-192 days). Matuchansky also questions whether the median lag time was shorter for patients with normal or equivocal results.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

October 23, 2013
Claude Matuchansky, MD
1Lariboisiere-St Louis Faculty of Medicine, Paris Diderot University, Paris, France
JAMA. 2013;310(16):1735. doi:10.1001/jama.2013.277449.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Related Topics
Jobs
brightcove.createExperiences();